Goldenwell Biotech, Inc. (GWLL)
OTCMKTS
· Delayed Price · Currency is USD
0.2000
0.00 (0.00%)
Apr 14, 2025, 4:00 PM EDT
Goldenwell Biotech Company Description
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States.
It is developing JI MAI—bovine cardiac vascular active peptide; Double Proline AG – 3D active collagen peptide; cartilage peptide, a type II collagen peptide; Se Plus tablets and sugar master tablets.
The company was incorporated in 2019 and is based in Hudson, Ohio.
Goldenwell Biotech, Inc.
| Country | United States |
| Founded | 2019 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| CEO | Shuang Liu |
Contact Details
Address: 581 Boston Mills Road Hudson, Nevada 44236 United States | |
| Phone | 440 666 7999 |
Stock Details
| Ticker Symbol | GWLL |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US38138N1046 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shuang Liu | Chairman, Chief Executive Officer and President |
| Hua Xie | Secretary, Principal Financial Officer, Principal Accounting Officer and Director |
| Li Yang | Treasurer and Director |